glp-1 supplement crackdown news FDA is moving to restrict mass-marketed compounded products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Maybe i’m not against compounding

doi: 10.3389/fcdhc.2025.1720794 Received 09 October 2025 Accepted 03 November 2025 Published 24 November 2025 Volume 6 - 2025 Edited by Marilena Vitale, Federico II University Hospital, Italy Reviewed by Theodoros Androutsakos, National and Kapodistrian University of Athens, Greece Gianpaolo Zerbini, San Raffaele Hospital (IRCCS), Italy Giovanna DAbbronzo, Federico II University Hospital, Italy Updates Copyright 2025 Codella, Senesi and Luzi

Manish Sahni, MD , we provide the tools and medical oversight necessary to help you feel confident before you even administer your first dose

Kodera et

*Correspondence: Jun Xu, [email protected] This article was submitted to Endocrinology of Aging, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers